Molecular control of B Lymphocyte growth and differentiation

STEM CELLS

Volumn 12, Issue 3, 1994, Pages 278-288

  Banchereau, J ^a   Briere F ^a   Liu, Y J ^a   Rousset, F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

B cells; CD40; Cytokines; Differentiation; Growth; IL 10; IL 2; IL 4

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; ANTIGEN BINDING; B LYMPHOCYTE DIFFERENTIATION; HUMAN; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NONHUMAN; PLASMA CELL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE;

ANIMAL; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; HUMAN; INTERLEUKINS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, B-CELL;

EID: 0028290352     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.5530120304     Document Type: Article

References (95)

1. Regulation of human B lymphocyte activation, proliferation and differentiation
2. Human B lymphocytes: phenotype, proliferation and differentiation
3. Human interleukin‐2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells
4. Human recombinant IL‐3 is a growth factor for normal B cells
5. B cell growth‐promoting activity of recombinant human interleukin‐4
6. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
7. Interleukin‐13, a novel T cellderived cytokine that regulates human monocyte and B cell function
8. B cell growth factor activity of interferon γ. Recombinant human interferon γ promotes proliferation of anti‐Ig activated human B lymphocytes
9. Human interferon‐γ acts as a B cell growth factor in the anti‐IgM antibody co‐stimulatory assay but has no direct B cell differentiation activity
10. Lymphotoxin is an important T cell‐derived growth factor for human B cells
11. Effect of tumor necrosis factor α on mitogen‐activated human B cells
12. Identification of a cDNA for a human high‐molecular‐weight B‐cell growth factor
13. Inhibitory influence of IL‐4 on human B cell responsiveness
14. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2
15. Human recombinant IL‐4 induces activated B lymphocytes to produce IgG and IgM
16. T cell‐dependent B cell activation
17. The CD40 and its ligand
18. The biology of the human ligand for CD40
19. Activation of human B lymphocytes through CD40 and interleukin 4
20. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50
21. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell‐specific antigen BP50 (CDw40)
22. Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL‐4 mediated signaling
23. Anti‐CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation
24. Identification of a source of biologically active CD40 ligand
25. Soluble CD40 ligand can replace the normal T cell‐derived CD40 ligand signal to B cells in T cell‐dependent activation
26. The human T antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity
27. Long term human B cell lines dependent on interleukin 4 and anti‐CD40
28. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion
29. The regulation of T cell‐dependent antibody formation in vitro by CD40 ligand and IL‐2
30. IL‐13 induces proliferation and differentiation of human B cells activated by the CD40 ligand
31. Human CD40‐ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production
32. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines
33. Proliferation and differentiation of human CD5+ and CD5‐ B cell subsets activated through their antigen receptors or CD40 antigens
34. Cytokineinduced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen
35. Interleukin‐13 is a new human lymphokine regulating inflammatory and immune responses
36. CD40 activated surface IgD positive lymphocytes constitute the long term IL‐4 dependent proliferating B cell pool
37. IL‐10 upregulates functional high affinity IL‐2 receptors on normal and leukemic B lymphocytes
38. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines
39. Interleukin 10 and transforming growth factor b̃ cooperate to induce anti‐CD40‐activated naive human B cells to secrete immunoglobulin A
40. Ligation of CD40 induces sterile transcripts of multiple Ig heavy chain isotypes in human B cells
41. CD40 and IgE: synergism between anti‐CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells
42. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones
43. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen
44. CD40 stimulation provides an IFN‐γ‐independent and IL‐4‐dependent differentiation signal directly to human B cells for IgE production
45. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2
46. Interleukin‐13 induces interleukin‐4‐independent IgG4 and IgE synthesis and CD23 expression by human B cells
47. Human interleukin 10 induces naive sIgD+ B cells to secrete IgG1 and IgG3
48. Transforming growth factor b̃ specifically enhances IgA production by lipopolysaccharide‐stimulated murine B lymphocytes
49. TGF‐b̃1 induces germ‐line transcripts of both IgA subclasses in human B lymphocytes
50. Theoretical and practical aspects of B‐cell activation: murine and human systems
51. Molecular and biological characterization of a murine ligand for CD40
52. The induction of human B‐cell activation, proliferation and differentiation by anti‐CD3‐stimulated T cells—a model of T cell/B cell collaboration
53. Cognate interactions between helper T cells and B cells
54. Cognate interactions between helper T cells and B cells. III.Contact‐dependent, lymphokine‐independent induction of B cell cycle entry by activated helper T cells
55. Stimulation of B‐cell proliferation by membrane‐associated molecules from activated T cells
56. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines
57. Membranes of activated CD4+ T cells expressing T cell receptor (TcR) αb̃ or TcR γδ induce IgE synthesis by human B cells in the presence of IL‐4
58. A 39‐kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
59. Identification of a novel surface protein on activated CD4+ T cells that induces contact‐dependent B cell differentiation (Help)
60. Immuno‐regulatory role of CD40 in human B cell differentiation
61. Role of CD40 antigen and interleukin‐2 in T cell dependent human B lymphocyte growth
62. CD40 ligand gene defects responsible for X‐linked hyper‐IgM syndrome
63. The CD40 ligand, gp39, is defective in activated T cells from patients with X‐linked hyper‐IgM syndrome
64. CD40 ligand mutations in X‐linked immunodeficiency with hyper‐IgM
65. Defective expression of T‐cell CD40 ligand causes X‐linked immunodeficiency with hyper‐IgM
66. Defective expression of the CD40 ligand in X chromosome‐linked immunoglobulin deficiency with normal or elevated IgM
67. In vivo CD40‐gp39 interactions are essential for thymus‐dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39
68. In vivo CD40–gp39 interactions are essential for thymus dependent humoral immunity. I.In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T‐B cell interactions
69. Antigen‐driven selection of virgin and memory B cells
70. Germinal center reaction and B lymphocytes
71. Germinal centres in T‐cell‐dependent antibody responses
72. The dendritic cell system and its role in immunogenicity
73. Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells, during primary antibody responses in vitro
74. Analysis of IL‐2, IL‐4, and IFN‐γ‐producing cells in situ during immune responses to protein antigens
75. In situ studies of the primary immune response to (4‐hydroxy‐3‐nitrophenyl) acetyl. I.The architecture and dynamics of responding cell populations
76. In situ studies of the primary immune response to (4‐hydroxy‐3‐nitrophenyl) acetyl. II. A common clonal origin for periarteriolar lymphoid sheath‐associated foci and germinal centers
77. Antigen‐driven B cell differentiation in vivo
78. Follicular dendritic cells contain a unique gene repertoire demonstrated by single‐cell polymerase chain reaction
79. GM‐CSF and TNF‐α cooperate in the generation of dendritic Langerhans cells
80. Germinal center cells expresbcl‐2 protein after activation by signals which prevent their entry into apoptosis
81. Germinal centers develop oligoclonally
82. Intraclonal generation of antibody mutants in germinal centres
83. Maturation of the immune response in germinal centers
84. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections
85. Mechanism of antigen‐driven selection in germinal centres
86. Growth factor requirements for the stimulation of germinal center B cells: evidence for an interleukin 2‐dependent pathway of development
87. T cells within germinal centers are specific for the immunizing antigen
88. Molecular interactions mediating T‐B lymphocyte collaboration in human lymphoid follicles. Roles of T cell‐B cell‐activating molecule (5c8 antigen) and CD40 in contact‐dependent help
89. Cytokine expression by germinal center cells
90. Interleukin‐6 and its receptor: a paradigm for cytokines
91. VLA‐4‐fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion
92. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma
93. Human recombinant IL‐3 stimulates B cell differentiation
94. Prevention of collagen‐induced arthritis with an antibody to gp39, the ligand for CD40